Innovations in Novel Stent Design, Diabetic Foot Ulcer Management, Automated Blood Glucose Monitoring, and PoC Breath Analyzer

Share this:
Published: 19 Jan 2018

The latest edition of Medical Device TOE profiles innovations in diverse markets such as coronary stents, shockwave therapy for diabetic foot ulcer management, continuous blood glucose monitoring, patient engagement platform, and continuous intravenous line monitoring. These innovations have been traced from across the globe - Singapore, Canada, Israel, Ireland and the United States, and represent a spectrum of technology readiness - pre-commercialization, new product launch, regulatory approval and so on. This mixed bag of innovation profiles also spans the industry and academia research groups. The Medical Device TechVision Opportunity Engine (TOE) analyzes and reports on new and emerging technologies and advances in R&D; product development; and regulatory matters related to neurology, ophthalmology, respiratory/anesthesia, wound care and management, surgical tools and instrumentation, drug delivery, orthopedics, endoscopy, cardiology, and monitoring. Medical devices and imaging technology and innovation research covers cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies, and imaging technologies and platforms. Keywords: Coronary stent, biomaterials, connected health, patient engagement, diabetic foot ulcer, shockwave, advanced wound care


Features of this research


Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..